{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T06:52:48Z","timestamp":1793083968223,"version":"4.5.0"},"reference-count":60,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens"],"abstract":"<jats:p>Background: Antimicrobial resistance is a threat that increases morbidity and mortality. This cross-sectional study aimed to describe the profile of priority antimicrobial-resistant pathogens and to analyze the behavior of multidrug-resistant tuberculosis (MDR-TB) in the Santiago de Cali District, Colombia. Methods: researchers compiled information from data provided by healthcare institutions, the National Public Health Surveillance System, and laboratory-based surveillance using the World Health Organization\u2019s WHONET v.5.6 software. Univariate statistical analysis described trends in pathogen resistance, and multivariate analysis analyzed the behavior of MDR-TB. Results: Among Gram-negative bacteria, high levels of carbapenem resistance were observed in A. baumannii (84% aztreonam resistance) and in K. pneumoniae (63%). P. aeruginosa exhibited elevated multidrug resistance, consistent with extensive antimicrobial selective pressure. MDR-TB exhibited a high burden of resistance, reaching 96%, with projections indicating a potential increase driven by monoresistance and resistance to rifampicin. Patients with drug-resistant tuberculosis who were HIV-positive or experiencing homelessness had a significantly higher likelihood of hospitalization (OR 5.59; 95% CI 3.09\u201310.11 and OR 2.94; 95% CI 1.48\u20135.81, respectively) and mortality (OR 3.34; 95% CI 1.72\u20136.49 and OR 2.59; 95% CI 1.16\u20135.79, respectively). Conclusions: The expansion of resistance mechanisms suggests sustained selective pressure, underscoring the need for strategies to optimize antibiotics.<\/jats:p>","DOI":"10.3390\/pathogens15030329","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T08:54:37Z","timestamp":1773910477000},"page":"329","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Profile of Priority Antimicrobial-Resistant Pathogens and the Behavior of Multidrug-Resistant Tuberculosis in the Santiago de Cali District, Colombia"],"prefix":"10.3390","volume":"15","author":[{"given":"Alejandra","family":"Mondrag\u00f3n Quiguanas","sequence":"first","affiliation":[{"name":"Santiago de Cali District Public Health Secretariat, Santiago de Cali Mayor\u2019s Office, Santiago de Cali 760045, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3081-1578","authenticated-orcid":false,"given":"Jorge Iv\u00e1n","family":"Montoya Salazar","sequence":"additional","affiliation":[{"name":"Santiago de Cali District Public Health Secretariat, Santiago de Cali Mayor\u2019s Office, Santiago de Cali 760045, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9705-2354","authenticated-orcid":false,"given":"Juan Camilo","family":"Mosquera-Hernandez","sequence":"additional","affiliation":[{"name":"Santiago de Cali District Public Health Secretariat, Santiago de Cali Mayor\u2019s Office, Santiago de Cali 760045, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margareth","family":"Zuluaga Aricapa","sequence":"additional","affiliation":[{"name":"Santiago de Cali District Public Health Secretariat, Santiago de Cali Mayor\u2019s Office, Santiago de Cali 760045, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Eduardo","family":"Pinz\u00f3n Fl\u00f3rez","sequence":"additional","affiliation":[{"name":"Santiago de Cali District Public Health Secretariat, Santiago de Cali Mayor\u2019s Office, Santiago de Cali 760045, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"German","family":"Escobar Morales","sequence":"additional","affiliation":[{"name":"Santiago de Cali District Public Health Secretariat, Santiago de Cali Mayor\u2019s Office, Santiago de Cali 760045, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1797-6379","authenticated-orcid":false,"given":"Johana Alejandra","family":"Moreno-Drada","sequence":"additional","affiliation":[{"name":"Faculty of Health, School of Dentistry, Universidad del Valle, Santiago de Cali 760043, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8949-7647","authenticated-orcid":false,"given":"Bruno","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[{"name":"Pacifico Siglo XXI Research Group, Department of Oral Public Health, Faculty of Health, School of Dentistry, Universidad del Valle, Santiago de Cali 760043, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy Marcela","family":"D\u00edaz Rivadeneira","sequence":"additional","affiliation":[{"name":"Santiago de Cali District Public Health Secretariat, Santiago de Cali Mayor\u2019s Office, Santiago de Cali 760045, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2022). The WHO AWaRe (Access, Watch, Reserve) Antibiotic Book, WHO. Available online: https:\/\/www.who.int\/publications\/b\/61917."},{"key":"ref_2","unstructured":"Instituto Nacional de Argentina Enfoque Una Salud: Estudios Ambientales de la Resistencia a Los Antimicrobianos, Ministerio de Salud. Available online: https:\/\/www.argentina.gob.ar\/sites\/default\/files\/bancos\/2023-11\/."},{"key":"ref_3","first-page":"172","article-title":"Resistencia antimicrobiana. Importancia y esfuerzos por contenerla","volume":"156","year":"2020","journal-title":"Gac. M\u00e9d. M\u00e9x."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"World Health Organization (2025). Global Antibiotic Resistance Surveillance Report 2025, WHO. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789240116337.","DOI":"10.2471\/B09585"},{"key":"ref_5","unstructured":"World Health Organization (2024). WHO Bacterial Priority Pathogens List, 2024: Bacterial Pathogens of Public Health Importance to Guide Research, Development and Strategies to Prevent and Control Antimicrobial Resistance, WHO. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789240093461."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S1473-3099(25)00118-5","article-title":"WHO Bacterial Priority Pathogens List Advisory Group. The WHO Bacterial Priority Pathogens List 2024: A prioritisation study to guide research, development, and public health strategies against antimicrobial resistance","volume":"25","author":"Sati","year":"2025","journal-title":"Lancet Infect Dis."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Polemis, M., Mandilara, G., Pappa, O., Argyropoulou, A., Perivolioti, E., Koudoumnakis, N., Pournaras, S., Vasilakopoulou, A., Vourli, S., and Katsifa, H. (2021). COVID-19 and Antimicrobial Resistance: Data from the Greek Electronic System for the surveillance of Antimicrobial Resistance-WHONET-Greece (January 2018\u2013March 2021). Life, 11.","DOI":"10.3390\/life11100996"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2147\/IDR.S344875","article-title":"Antimicrobial resistance among pathogens causing bloodstream infections: A multicenter surveillance report over 20 years (1998\u20132017)","volume":"15","author":"Zhang","year":"2022","journal-title":"Infect. Drug Resist."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"6155","DOI":"10.2147\/IDR.S429687","article-title":"Antimicrobial Resistance Patterns of Staphylococcus aureus and Enterococcus Species at the Ethiopian Public Health Institute, Ethiopia: A Five-Year Retrospective Analysis","volume":"16","author":"Abdeta","year":"2023","journal-title":"Infect. Drug Resist."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1600803","DOI":"10.1183\/13993003.00803-2016","article-title":"An updated systematic review and meta-analysis for treatment of multidrug-resistant tuberculosis","volume":"49","author":"Bastos","year":"2017","journal-title":"Eur. Respir. J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"102011","DOI":"10.1016\/j.tube.2020.102011","article-title":"Population structure of multidrug-resistant Mycobacterium tuberculosis clinical isolates in Colombia","volume":"125","author":"Llerena","year":"2020","journal-title":"Tuberculosis"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"71","DOI":"10.7705\/biomedica.v39i2.3924","article-title":"MIRU-VNTR genotyping of Mycobacterium tuberculosis in a population of patients in Cali, Colombia, 2013\u20132015","volume":"39","author":"Astudillo","year":"2019","journal-title":"Biomedica"},{"key":"ref_13","unstructured":"World Health Organization (2024). Global Tuberculosis Report 2024, WHO."},{"key":"ref_14","unstructured":"World Health Organization (2025). TB Profile, WHO. Available online: https:\/\/worldhealthorg.shinyapps.io\/tb_profiles\/."},{"key":"ref_15","unstructured":"Clinical and Laboratory Standards Institute (CLSI) (2016). Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria, CLSI. [3rd ed.]. CLSI document M45."},{"key":"ref_16","unstructured":"Clinical and Laboratory Standards Institute (CLSI) (2024). Performance Standards for Antimicrobial Susceptibility Testing, CLSI. [34th ed.]."},{"key":"ref_17","unstructured":"Clinical and Laboratory Standards Institute (CLSI) (2020). Performance Standards for Antimicrobial Susceptibility Testing, CLSI. [30th ed.]. CLSI supplement M100."},{"key":"ref_18","unstructured":"Instituto Nacional de Salud (Colombia) (2025, September 25). Vigilancia de la Resistencia a F\u00e1rmacos Antituberculosis en Casos Previamente Tratados a Partir de Muestras de Esputo Durante el a\u00f1o 2014, Available online: https:\/\/www.ins.gov.co\/buscador\/Informacin%20de%20laboratorio\/Vigilancia%20de%20resistencia%20a%20f%C3%A1rmacos%20antituberculosis%20en%20pacientes%20pre%20tratados.pdf."},{"key":"ref_19","unstructured":"Instituto Nacional de Salud (Colombia) (2025, September 25). Gu\u00eda Para la Vigilancia de Tuberculosis por el Laboratorio, Available online: https:\/\/www.ins.gov.co\/BibliotecaDigital\/guia-para-la-vigilancia-de-tuberculosis-por-el-laboratorio.pdf."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"427","DOI":"10.15585\/mmwr.mm7012a4","article-title":"Epidemiology of Tuberculosis and Progress Toward Meeting Global Targets\u2014Worldwide, 2019","volume":"70","author":"Fukunaga","year":"2021","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","article-title":"Global burden of bacterial antimicrobial resistance 1990\u20132021: A systematic analysis with forecasts to 2050","volume":"404","author":"Naghavi","year":"2024","journal-title":"Lancet"},{"key":"ref_22","unstructured":"World Health Organization (2023). Antimicrobial Resistance, WHO. Available online: https:\/\/www.who.int\/es\/news-room\/fact-sheets\/detail\/antimicrobial-resistance."},{"key":"ref_23","unstructured":"Instituto Nacional de Salud (2024). Informe de Evento 2023 Tuberculosis Farmacorresistente, INS."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/14787210.2020.1813023","article-title":"Update on the epidemiology of carbapenemases in Latin America and the Caribbean","volume":"19","author":"Appel","year":"2021","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e04105-23","DOI":"10.1128\/spectrum.04105-23","article-title":"First report of KPC variants conferring ceftazidime-avibactam resistance in Colombia: Introducing KPC-197","volume":"12","author":"Mojica","year":"2024","journal-title":"Microbiol. Spectr."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e0180525","DOI":"10.1128\/spectrum.01805-25","article-title":"Emergence and dissemination of blaKPC-31 and blaPAC-2 among different species of Enterobacterales in Colombia: A new challenge for the microbiological laboratories","volume":"13","author":"Castro","year":"2025","journal-title":"Microbiol. Spectr."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Pallares, C., Hern\u00e1ndez-G\u00f3mez, C., Appel, T.M., Escand\u00f3n, K., Reyes, S., Salcedo, S., Matta, L., Mart\u00ednez, E., Cobo, S., and Mora, L. (2022). Impact of antimicrobial stewardship programs on antibiotic consumption and antimicrobial resistance in four Colombian healthcare institutions. BMC Infect. Dis., 22.","DOI":"10.1186\/s12879-022-07410-6"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/14787210.2017.1268918","article-title":"The epidemiology of carbapenemases in Latin America and the Caribbean","volume":"15","author":"Reyes","year":"2017","journal-title":"Expert. Rev. Anti Infect. Ther."},{"key":"ref_29","unstructured":"Instituto Nacional de Salud (2025, May 04). Informe de Evento y Tableros de Control, Tuberculosis Farmacorresistente, Available online: https:\/\/www.ins.gov.co\/buscador-eventos\/Paginas\/Info-Evento.aspx."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Mancuso, G., Midiri, A., De Gaetano, S., Ponzo, E., and Biondo, C. (2023). Tackling Drug-Resistant Tuberculosis: New Challenges from the Old Pathogen Mycobacterium tuberculosis. Microorganisms, 11.","DOI":"10.20944\/preprints202308.2059.v1"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: The WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1179\/2047773215Y.0000000030","article-title":"Antimicrobial resistance: A global multifaceted phenomenon","volume":"109","author":"Prestinaci","year":"2015","journal-title":"Pathog. Glob. Health"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"482","DOI":"10.7705\/biomedica.v30i4.286","article-title":"Caracter\u00edsticas cl\u00ednicas, epidemiol\u00f3gicas y microbiol\u00f3gicas de una cohorte de pacientes con tuberculosis pulmonar en Cali, Colombia","volume":"30","author":"Rojas","year":"2010","journal-title":"Biomedica"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"447","DOI":"10.7705\/biomedica.6842","article-title":"Tuberculosis multirresistente en Colombia, 2013\u20132018: Estudio de casos y controles","volume":"43","author":"Puerto","year":"2023","journal-title":"Biomedica"},{"key":"ref_36","first-page":"171","article-title":"Resistencia a f\u00e1rmacos antituberculosis en pacientes coinfectados con tuberculosis y VIH en un hospital de referencia de Cali, 2007\u20132010","volume":"16","author":"Paz","year":"2012","journal-title":"Infectio"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/tmi.13453","article-title":"Prevalence of multidrug-resistant tuberculosis in Latin America and the Caribbean: A systematic review and meta-analysis","volume":"25","author":"Tengan","year":"2020","journal-title":"Trop. Med. Int. Health"},{"key":"ref_38","first-page":"e320\u201330","article-title":"Mortality from drug-resistant tuberculosis in high-burden countries comparing routine drug susceptibility testing with whole-genome sequencing: A multicentre cohort study","volume":"2","author":"Reichmuth","year":"2021","journal-title":"Lancet Microbe"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Alemu, A., Bitew, Z.W., Worku, T., Gamtesa, D.F., and Alebel, A. (2021). Predictors of mortality in patients with drug-resistant tuberculosis: A systematic review and meta-analysis. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0253848"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Seeberg, J. (2023). An Epidemic of Drug Resistance: Tuberculosis in the Twenty-First Century. Pathogens, 12.","DOI":"10.3390\/pathogens12050652"},{"key":"ref_41","unstructured":"Ministerio de Salud y Protecci\u00f3n Social (2020). Resoluci\u00f3n No. 227 de 2020. Lineamientos T\u00e9cnicos y Operativos del Programa Nacional de Prevenci\u00f3n y Control de la Tuberculosis-PNPCT, MiniSalud."},{"key":"ref_42","unstructured":"World Health Organization (2024). WHO Consolidated Guidelines on Tuberculosis: Module 3: Diagnosis: Rapid Diagnostics for Tuberculosis Detection, WHO. [3rd ed.]. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789240089488."},{"key":"ref_43","unstructured":"World Health Organization (2024). 1.3 Drug-Resistant TB, World Health Organization. Available online: https:\/\/www.who.int\/teams\/global-programme-on-tuberculosis-and-lung-health."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"360","DOI":"10.7705\/biomedica.6961","article-title":"Factors associated with unsuccessful treatment outcome for tuberculosis in previously treated patients in Cali, Colombia, 2015\u20132019","volume":"43","author":"Varela","year":"2023","journal-title":"Biomedica"},{"key":"ref_45","unstructured":"World Health Organization (2015). The End TB Strategy, WHO. Available online: https:\/\/www.who.int\/publications\/i\/item\/WHO-HTM-TB-2015.19."},{"key":"ref_46","unstructured":"World Health Organization (2022). Implementing the End TB Strategy: The Essentials; 2022 update, WHO."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S1473-3099(24)00007-0","article-title":"Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: A systematic analysis for the Global Burden of Disease Study 2021","volume":"24","author":"Ledesma","year":"2024","journal-title":"Lancet Infect Dis."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"(2022). Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. Lancet, 399, 629\u2013655. Erratum in Lancet 2022, 400, 1102. https:\/\/doi.org\/10.1016\/S0140-6736(21)02653-2.","DOI":"10.1016\/S0140-6736(21)02653-2"},{"key":"ref_49","unstructured":"World Health Organization (2016). Global Action Plan on Antimicrobial Resistance, WHO. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789241509763."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e1225","DOI":"10.1016\/S2214-109X(24)00229-8","article-title":"A successful UN High-Level Meeting on antimicrobial resistance must build on the 2023 UN High-Level Meeting on tuberculosis","volume":"12","author":"Cirillo","year":"2024","journal-title":"Lancet Glob Health"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1016\/S2666-5247(20)30195-6","article-title":"Globally diverse Mycobacterium tuberculosis resistance acquisition: A retrospective geographical and temporal analysis of whole genome sequences","volume":"2","author":"Ektefaie","year":"2021","journal-title":"Lancet Microbe"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Vasiliu, A.M.I., Saluzzo, F., Akkerman, O.W., Loveday, M., Morita, A., Saktiawati, I., and Lange, C. (2024). Strategies to Enhance Diagnostic Capabilities for the New Drug-Resistant Tuberculosis (DR-TB) Drugs. Pathogens, 13.","DOI":"10.3390\/pathogens13121045"},{"key":"ref_53","unstructured":"(2023). World Health Organization; Food and Agriculture Organization of the United Nations; United Nations Environment Programme; World Organisation for Animal Health. A Guide to Implementing the One Health Joint Plan of Action at National Level, WHO. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789240082069."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.tube.2008.07.003","article-title":"Potential challenges to the Stop TB Plan for humans in China: Cattle maintain M. bovis and M. tuberculosis","volume":"89","author":"Chen","year":"2009","journal-title":"Tuberculosis"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.vetmic.2016.12.013","article-title":"Molecular identification of Mycobacterium tuberculosis in cattle","volume":"198","author":"Sweetline","year":"2017","journal-title":"Vet. Microbiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.prevetmed.2018.06.012","article-title":"Epidemiology of Mycobacterium bovis and Mycobacterium tuberculosis in animals: Transmission dynamics and control challenges of zoonotic TB in Ethiopia","volume":"158","author":"Romha","year":"2018","journal-title":"Prev. Vet. Med."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Aslam, B., Khurshid, M., Arshad, M.I., Muzammil, S., Rasool, M., Yasmeen, N., Shah, T., Chaudhry, T.H., Rasool, M.H., and Shahid, A. (2021). Antibiotic Resistance: One Health One World Outlook. Front. Cell Infect. Microbiol., 11.","DOI":"10.3389\/fcimb.2021.771510"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s10393-018-1325-6","article-title":"Prioritizing a One Health Approach in the Immediate Fight Against Antimicrobial Resistance","volume":"16","author":"Ogawa","year":"2019","journal-title":"Ecohealth"},{"key":"ref_59","first-page":"743","article-title":"Antimicrobial resistance: One Health approach","volume":"15","year":"2022","journal-title":"Vet. World"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1007\/s10311-021-01238-3","article-title":"Antimicrobial resistance dynamics and the One Health strategy: A review","volume":"19","author":"Singh","year":"2021","journal-title":"Environ. Chem. Lett."}],"container-title":["Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-0817\/15\/3\/329\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T09:19:16Z","timestamp":1773911956000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-0817\/15\/3\/329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":60,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["pathogens15030329"],"URL":"https:\/\/doi.org\/10.3390\/pathogens15030329","relation":{},"ISSN":["2076-0817"],"issn-type":[{"value":"2076-0817","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]}}}